Similarly, DOXY structural analog tigecycline was recently shown to induce ISR via GCN2 signaling in colorectal adenocarcinoma and chronic myelogenous leukemia cells [73]. The gene discussed is EIF2AK4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.